抗 CD22/CD19 CAR-T 细胞疗法 CAR-T2219.1 在成人和儿童复发/难治性 B-ALL 中的 I/II 期试验
A Phase I/II Trial of Anti-CD22/CD19 CAR-T Cell Therapy, CART2219.1, in Adult and Pediatric Relapsed/Refractory B-ALL.
英文原题:Accurate vector copy number determination in gammaretroviral vector producer cell clones using triplex digital droplet PCR.
Accurate vector copy number determination in gammaretroviral vector producer cell clones using triplex digital droplet PCR.
分数与星级只用于站内排序 —— 不代表疗效、安全性或个人适用性。
由于存在稳定的载体生产细胞,γ逆转录病毒载体被广泛用于细胞和基因治疗产品。准确评估载体拷贝数(VCN)对于选择合适克隆至关重要,可避免同源重组风险和突变检测复杂性。定量聚合酶链式反应(PCR)和Southern印迹等传统方法在准确性和通量方面存在局限。
本研究提出一种三重液滴数字PCR(ddPCR)方法,用于分析γ逆转录病毒载体生产细胞中的VCN。我们设计了一组通用引物-探针,靶向鼠白血病病毒和鼠干细胞病毒来源γ逆转录病毒载体共有的包装信号序列。对PG13 γ逆转录病毒载体包装细胞系进行核型分析后,选择两个参考基因以识别稳定染色体。
我们使用不同转基因和载体骨架构建体转导PG13细胞,对三重ddPCR检测进行优化和验证。该检测结果与Southern印迹高度一致。使用多个参考基因可确保VCN评估准确且稳健,尤其适用于染色体不稳定的细胞系。该方法改进了γ逆转录病毒载体生产细胞的克隆筛选流程,可加速新型细胞和基因治疗产品开发,并确保其快速提供给患者。
Gammaretroviral vectors are widely used in cellular and gene therapy products because of the availability of stable vector producer cells. Accurately assessing vector copy number (VCN) is critical for selecting appropriate clones to avoid the risks of homologous recombination and complications in mutation detection. Traditional methods such as quantitative polymerase chain reaction (PCR) and Southern blotting have limitations in accuracy and throughput.
This study presents a triplex droplet digital PCR (ddPCR) method for analyzing the VCN in gammaretroviral vector producer cells.
We designed a universal primer- probe set targeting the packaging signal sequence common to murine leukemia virus- and murine stem cell virus- based gammaretroviral vectors. Two reference genes were selected after karyotyping the PG13 gammaretroviral vector packaging cell line to identify stable chromosomes. The triplex ddPCR assay was optimized and verified using PG13 cells transduced with constructs of different transgene and vector backbones.
The assay showed high concordance with Southern blot. Using multiple reference genes ensures accurate and robust VCN assessment, especially in cell lines with chromosomal instability. This method improves the clone selection process for gammaretroviral vector producer cells, accelerates the development of novel cellular and gene therapy products, and ensures their rapid delivery to patients.
MEMBER ACCOUNT
登录成功会直接打开下一页。